Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/220752


An Evaluation of Product Usage for Molecular Testing within Infectious Diseases - Norway, Denmark, Sweden, Finland, Belgium and Switzerland


Description: This report examines the reality of laboratories and hospitals in 6 European countries and provides you with following information:

Molecular Tests
- Description of laboratory landscape per country
- the number of performed tests for 47 pathogens
- which products, technologies and manufacturers are used per pathogen
- determine current laboratory equipment that is used for microbiology testing
- Unmet needs
- which tests, technologies and products show the most promising market opportunities in the short tmedium term
- market potential in volume per test, technology and country
- regulatory issues per country (legislation, reimbursement

Product Value Proposition
The study will allow the owner of the information to:
- Assess current market realities in terms of currently performed tests / Used technologies at an unparalleled level of segmentation
- Get detailed knowledge on suppliers of molecular test kits / equipment, (by segmentation criteria)
- Reflect the current situation not only at a specific point in time, but monitor trends over a period of time (both in terms of market participants as well as system types)
- Model market and own sales forecasts on system types based on investment plans of customers
- Reflect the expected behaviour of buyers, not just the expectations of sellers; but by the motivations of buyers.
- Model market forecasts on associated product lines (e.g. PCR Cycler, NAT related devices) based on procedure data
- Make decisions regarding the market entry/marketing strategy

Respondents have been chosen randomly in order to guarantee that the respondents reflect the real market situation. However the definition of the project required the focus on such institutions that perform molecular testing particularly.

Segmentation by Indication
- STD
Chlamydia trachomatis
Neisseria gonorrhoeae
HIV
HCV

- Mycobacteria
Mycobacterium tuberculosis
Mycobacterium avium

- Atypical Pneumoniae
Bordetella sp.
Legionella pneumophilia
Chlamydia sp.
Mycoplasma pneumoniae

- CMV
quantitative
qualitative

- Virale Meningitis/Encephalitis
HSV 1,2
Enterovirus
West Nile Virus

- Respiratory Virus
SARS
Adenovirus
Influenza A
Influenza A and B
RSV
Parainfluenza

- HPV

- Chronic Meningitis
Blastomyces
Histoplasma
Cryptococcus
Coccidioides
TB

- Bacterial Meningitis
Neisseria meningitidis
Haemophilus
Pneumokokken
Listeria
Enterobacteriacea/Nonfermentors

- Tick Born Encephalitis
RMSF
Babesia
Ehrlichia
Anaplasma
Borrelia

- MRSA

- Fungi

Segmentation by Technology
- commercial available tests with amplification (methods: PCR, LCR, SDA)
- Commercial tests without amplification (method: DNA probes)
- Others: EIA (enzyme linked tests), Antibody/Antigencomplex tests, serology, microscopy, strip tests

Segmentation by Country
- Norway
- Denmark
- Sweden
- Finland
- Belgium
- Switzerland


Contents: 1.1 Project Objectives
1.2 Definitions
1.3 Health Care System and Reimbursement
- Healthcare System
- Reimbursement Policies
- Private Laboratories - EBM
- Hospital Laboratories
- Maternity Services
- IGeL - Individual Health Services
1.4 Laboratory Landscape
1.5 Respondent Population

2. Infectious Diseases Testing in Clinical Laboratories
2.1 Sexual Transmitted Diseases (STD)
- Chlamydia Trachomatis
- Neisseria
- HIV
- HCV
- Group B Streptococcus
- HSV
2.2 Mycobacteria
- Mycobacteria Tuberculosis
- Mycobacteria Avium
- Mycobacteria – NA Purification

2.3 Atypical Pneumoniae
- Bordetella
- Legionella
- Chlamydia sp.
- Mycoplasma Pneumoniae

2.4 Cytomegalovirus (CMV)
- CMV – Qualitative Tests
- CMV – Quantitative Tests

2.5. Viral Meningitis
- HSV 1 & 2
- Enterovirus
- West Nile Virus (WNV)
- Epstein Barr Virus (EBV)
- VZV

2.6 Respiratory Viruses
- SARS
- Adenovirus
- Influenza A
- Influenza A&B
- RSV
- Parainfluenza

2.7 HPV
2.8 Chronic Meningitis
2.9 Bacterial Meningitis
- Neisseria Meningitis
- Haemophilus Influenza
- Pneumococcae
- Listeria
- Enterobacteria
2.10 Tick Born Encephalitis
2.11 Antibiotic Resistant Bacteria
- MRSA
- VRE
2.12 Candida

3. Equipment & Purchase
3.1 Current Installations & Financing of Laboratory Equipment
- Cobas Amplicor, Roche
- Light Cycler, Roche
- ABI PRISM, Applied Biosystems
- RotorGene, Corbett Research
- Other Cycler
- Other Devices/Manufacturers
3.2 Budget Resources
3.3 Who is Involved in Purchasing Decisions
3.4 How do Laboratories Purchase
3.5 Criteria Influence a Purchasing Decision
3.6 What are Laboratories Willing to Pay for New Tests?

4. Market Sizes and Market Shares
4.1 Market Volumes for Selected Pathogens
- STD
- Mycobacteria Tuberculosis
- Atypical Pneumonia
- CMV
- Viral Meningitis
- Respiratory Viruses
- HPV
- MRSA
4.2 Market Shares

5. Market Trends
5.1 Problems with Molecular Diagnostics
5.2 Expected Growth per Segment
5.3 Other Growth Areas
5.4 Drivers for Molecular Diagnostics
5.5 Restraints for Molecular Diagnostics

6. Political Influences
6.1 Changes of Reimbursement Policy
6.2 Influence of the EU IVD Act




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/220752

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 07:35:17
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
An Evaluation of Product Usage for Molecular Testing within Infectious Diseases - Norway, Denmark, Sweden, Finland, Belgium and Switzerland
Web Address:
http://www.researchandmarkets.com/reports/220752
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €4,500.00 + EUR€ 50.00 Shipping/Handling *
Electronic €4,500.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 07:35:17

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)